CORZ: Colocation growth accelerated as 1.1 GW of contracted capacity advances toward delivery

What happened

Core Scientific reported that third-quarter colocation revenue rose nearly 60% sequentially to $215 million and adjusted EBITDA reached $134 million. The article says growth is backed by 1.1 gigawatts of contracted capacity advancing toward delivery, with AMD financing, permitting, and execution still priorities.

Confirmed

Global impact / market context

Higher colocation revenue and adjusted EBITDA indicate that this business is contributing more to reported results. Delivering the contracted capacity could support further growth, but financing, permits, and execution are prerequisites; delays or funding gaps could postpone revenue and limit the cash available for operations or investment.

Analyst inference

The update combines rapid quarter-to-quarter revenue growth with a large contracted capacity figure, but does not say when all capacity will be delivered or detail the remaining AMD financing. Investors therefore have evidence of demand and current growth, alongside unresolved delivery and funding risks.

Analyst inference

What to watch

1. Check subsequent results for colocation revenue and adjusted EBITDA, which is a profit measure adjusted for selected items, to see whether recent growth continues. Analyst inference
2. Look for updates on AMD financing, permitting, and execution; these are identified as priorities, but the article gives no completion dates or financing amounts. Confirmed
3. Track progress toward delivering the 1.1 gigawatts of contracted capacity, since delays could defer the revenue growth investors may expect from those agreements. Analyst inference

Evidence

• Original source link unavailable